Publication | Open Access
Pneumonia risk with inhaled fluticasone furoate and vilanterol in COPD patients with moderate airflow limitation: The SUMMIT trial
36
Citations
20
References
2017
Year
AsthmaAllergyAdvanced Lung DiseaseRespiratory DiseasesPulmonary FibrosisPulmonary MedicineModerate Airflow LimitationMedicinePulmonary DiseasePneumonia RiskSummit Trial
| Year | Citations | |
|---|---|---|
Page 1
Page 1